412 related articles for article (PubMed ID: 29130633)
1. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
[TBL] [Abstract][Full Text] [Related]
2. Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice.
Gatta L; Vitiello L; Gorini S; Chiandotto S; Costelli P; Giammarioli AM; Malorni W; Rosano G; Ferraro E
Oncotarget; 2017 Dec; 8(69):113938-113956. PubMed ID: 29371959
[TBL] [Abstract][Full Text] [Related]
3. Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury.
Song M; Chen FF; Li YH; Zhang L; Wang F; Qin RR; Wang ZH; Zhong M; Tang MX; Zhang W; Han L
J Cachexia Sarcopenia Muscle; 2018 Feb; 9(1):106-118. PubMed ID: 29152896
[TBL] [Abstract][Full Text] [Related]
4. The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes.
Ferraro E; Giammarioli AM; Caldarola S; Lista P; Feraco A; Tinari A; Salvatore AM; Malorni W; Berghella L; Rosano G
FEBS J; 2013 Oct; 280(20):5094-108. PubMed ID: 23953053
[TBL] [Abstract][Full Text] [Related]
5. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
6. Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations.
Ballarò R; Beltrà M; De Lucia S; Pin F; Ranjbar K; Hulmi JJ; Costelli P; Penna F
FASEB J; 2019 Apr; 33(4):5482-5494. PubMed ID: 30653354
[TBL] [Abstract][Full Text] [Related]
7. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
9. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.
Pigna E; Berardi E; Aulino P; Rizzuto E; Zampieri S; Carraro U; Kern H; Merigliano S; Gruppo M; Mericskay M; Li Z; Rocchi M; Barone R; Macaluso F; Di Felice V; Adamo S; Coletti D; Moresi V
Sci Rep; 2016 May; 6():26991. PubMed ID: 27244599
[TBL] [Abstract][Full Text] [Related]
10. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
[TBL] [Abstract][Full Text] [Related]
11. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
[TBL] [Abstract][Full Text] [Related]
12. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
Conte E; Camerino GM; Mele A; De Bellis M; Pierno S; Rana F; Fonzino A; Caloiero R; Rizzi L; Bresciani E; Ben Haj Salah K; Fehrentz JA; Martinez J; Giustino A; Mariggiò MA; Coluccia M; Tricarico D; Lograno MD; De Luca A; Torsello A; Conte D; Liantonio A
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):386-404. PubMed ID: 28294567
[TBL] [Abstract][Full Text] [Related]
14. Compound Z526 alleviates chemotherapy-induced cachectic muscle loss by ameliorating oxidative stress-driven protein metabolic imbalance and apoptosis.
Gu X; Lu S; Fan M; Xu S; Lin G; Zhao Y; Zhao W; Liu X; Dong X; Zhang X
Eur J Pharmacol; 2024 Jul; 974():176538. PubMed ID: 38552940
[TBL] [Abstract][Full Text] [Related]
15. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia.
Sirago G; Conte E; Fracasso F; Cormio A; Fehrentz JA; Martinez J; Musicco C; Camerino GM; Fonzino A; Rizzi L; Torsello A; Lezza AMS; Liantonio A; Cantatore P; Pesce V
Sci Rep; 2017 Oct; 7(1):13017. PubMed ID: 29026190
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming Promotes Myogenesis During Aging.
Belli R; Bonato A; De Angelis L; Mirabilii S; Ricciardi MR; Tafuri A; Molfino A; Gorini S; Leigheb M; Costelli P; Caruso M; Muscaritoli M; Ferraro E
Front Physiol; 2019; 10():897. PubMed ID: 31354530
[TBL] [Abstract][Full Text] [Related]
18. Trimetazidine and exercise provide comparable improvements to high fat diet-induced muscle dysfunction through enhancement of mitochondrial quality control.
Zhang W; You B; Qi D; Qiu L; Ripley-Gonzalez JW; Zheng F; Fu S; Li C; Dun Y; Liu S
Sci Rep; 2021 Sep; 11(1):19116. PubMed ID: 34580406
[TBL] [Abstract][Full Text] [Related]
19. Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse.
Aulino P; Berardi E; Cardillo VM; Rizzuto E; Perniconi B; Ramina C; Padula F; Spugnini EP; Baldi A; Faiola F; Adamo S; Coletti D
BMC Cancer; 2010 Jul; 10():363. PubMed ID: 20615237
[TBL] [Abstract][Full Text] [Related]
20. Colon 26 adenocarcinoma (C26)-induced cancer cachexia impairs skeletal muscle mitochondrial function and content.
Neyroud D; Nosacka RL; Judge AR; Hepple RT
J Muscle Res Cell Motil; 2019 Mar; 40(1):59-65. PubMed ID: 30945134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
